ADVERTISEMENT

Police lieutenant dies of COVID-19 despite getting CoronaVac jab

Published Apr 30, 2021 11:04 am

A police lieutenant who had been inoculated last month with one dose of the China-made CoronaVac vaccine has died of the coronavirus disease (COVID-19), the Philippine National Police (PNP) said Friday, April 30.

(Mark Balmores/ File photo/ MANILA BULLETIN)

The 50-year-old fatality was an officer from Calabarzon (Region 4A) and assigned at the National Support Operations Unit (NSOU), a report submitted by the PNP Health Service to PNP Chief Gen. Debold Sinas bared.

The same report said that the unnamed cop was given his first dose of the Sinovac Biotech Ltd.-manufactured vaccine last March 31. He was included among the priority personnel of the PNP since he had a comorbidity.

However, a week after the inoculation, the cop experienced symptoms of COVID-19 such as headache, sore throat, cough, and difficulty in breathing, the report said.

He underwent a reverse transcription polymerase chain reaction (RT-PCR) test which eventually yielded a positive result, it added.

Despite undergoing medication, the oxygen saturation of the cop continued to plummet to a critical level, which led to his hospitalization in Batangas on April 15.

On April 28, the cop was scheduled for hemoperfusion, a procedure where a person's blood is filtered to remove toxins and decrease the level of inflammation and organ dysfunction in critically ill patients.

The PNP-NOSU immediately coordinated with various hospitals in Calabarzon and Metro Manila that could perform the treatment "but no hospitals currently admitting outside patients due to full capacity," the report said. The cop was placed on the waiting list.

On Thursday, April 29, the cop was declared dead by his attending physician, making him the 56th COVID-related fatality in the PNP.

"I would like to express my heartfelt condolences to the bereaved family. As frontliners every PNP personnel is risking their own safety, the least that we could do is to assure them that we would be there for them and their family to extend all the necessary support," Sinas said.

As of April 29, the PNP has already recorded 20,150 cases of COVID-19. Of the figure, 1,722 are active cases, while 18,372 cases have been declared as recoveries.

The efficacy of the CoronaVac vaccine--which requires two doses--was again put into question with the death of the vaccinated cop.

According to the Department of Health (DOH), CoronaVac has an efficacy rate of 91.6 percent against symptomatic COVID-19 after 21 days of inoculation from the first dose.

The DOH added that the Chinese vaccine is also deemed 100 percent effective against moderate or severe infection after 21 days of inoculation from the first dose.

Related Tags

calabarzon covid-19 CoronaVac Sinovac vaccines PNP Philippines china
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.